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Abstract
Notch signaling is an evolutionarily conserved signal transduction
pathway that is essential for metazoan development. Upon ligand
binding, the Notch intracellular domain (NOTCH ICD) translocates
into the nucleus and forms a complex with the transcription factor
RBPJ (also known as CBF1 or CSL) to activate expression of Notch
target genes. In the absence of a Notch signal, RBPJ acts as a tran-
scriptional repressor. Using a proteomic approach, we identified
L3MBTL3 (also known as MBT1) as a novel RBPJ interactor. L3MBTL3
competes with NOTCH ICD for binding to RBPJ. In the absence of
NOTCH ICD, RBPJ recruits L3MBTL3 and the histone demethylase
KDM1A (also known as LSD1) to the enhancers of Notch target
genes, leading to H3K4me2 demethylation and to transcriptional
repression. Importantly, in vivo analyses of the homologs of RBPJ
and L3MBTL3 in Drosophila melanogaster and Caenorhabditis elegans
demonstrate that the functional link between RBPJ and L3MBTL3 is
evolutionarily conserved, thus identifying L3MBTL3 as a universal
modulator of Notch signaling in metazoans.
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Introduction
The Notch signal transduction pathway is a conserved signaling
mechanism that is fundamental for morphogenesis in multicellular
organisms (Bray, 2006; Kopan & Ilagan, 2009; Hori et al, 2013). The
biological action of Notch is highly pleiotropic, and impaired Notch
signaling leads to a broad spectrum of developmental disorders
(Louvi & Artavanis-Tsakonas, 2012) and many types of cancer
(Aster et al, 2017). The developmental outcome of Notch signaling
is strictly dependent on the cell context and can influence cell fate
in a remarkable number of different ways, for example, differentia-
tion, proliferation, and apoptosis (Bray, 2006; Kopan & Ilagan, 2009;
Hori et al, 2013). Thus, various context-specific mechanisms, many
of which likely remain to be uncovered, allow the Notch building
block to be “re-used” in different flavors at various junctures within
the developmental framework. Identifying these context-specific
modulators of Notch signaling is not only essential to understanding
the plasticity of Notch as a regulator of cell fate during morphogene-
sis, but it could also provide novel clues to manipulating Notch for
therapeutic benefit in human diseases.
At the molecular level, canonical Notch signaling involves the
binding of a membrane-bound DSL (Delta, Serrate, Lag-2)-family
ligand presented on the cell surface of one cell to the Notch
transmembrane receptor located on a neighboring cell (Bray,
2006; Kopan & Ilagan, 2009; Hori et al, 2013). Upon ligand
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binding, the NOTCH receptor is processed by proteolytic cleav-
ages, leading to the release of its intracellular domain (NOTCH
ICD) into the cytoplasm. NOTCH ICD traffics to the nucleus and
complexes with the DNA-binding transcription factor CSL to regu-
late target genes. The CSL gene, which is the main focus of this
study, is also known as CBF1/RBPJ in vertebrates, Suppressor of
Hairless [Su(H)] in Drosophila melanogaster, and lag-1 in
Caenorhabditis elegans. As previously observed for Su(H) in
Drosophila, mammalian RBPJ has a dual role in regulating Notch
signaling (Bray, 2006; Kopan & Ilagan, 2009; Tanigaki & Honjo,
2010). Upon Notch activation, NOTCH ICD, RBPJ, and additional
co-activators form the Notch transcriptional activation complex
(NTC) that supports the expression of target genes (Wang et al,
2015). In the absence of NOTCH ICD, RBPJ interacts with multi-
ple transcriptional co-repressors, for example, KYOT2 or MINT
and inhibits transcription of Notch target genes (Borggrefe &
Oswald, 2014). As such, the role of RBPJ is multifaceted and
context dependent (Bray, 2006; Kopan & Ilagan, 2009; Tanigaki &
Honjo, 2010). In some contexts, for example, marginal zone B-
cell development (Zhang et al, 2012) or maintenance of muscle
progenitor cells (Vasyutina et al, 2007), loss of RBPJ results in
the inhibition of Notch target genes and blocks the regulation of
Notch-driven physiological states. In other contexts, for example,
maintenance of adult neural stem cell population (Fujimoto et al,
2009) or breast tumorigenesis (Kulic et al, 2015), loss of RBPJ
contributes to the “de-repression” of Notch target genes and
results in the promotion of biological processes that are otherwise
suppressed in the absence of Notch signaling. Identifying the
molecular partners of RBPJ will help to better understand the
complex and context-dependent role of RBPJ in the regulation of
Notch signaling in both normal and disease contexts.
We generated a map of the Notch molecular network by using
two complementary proteomic approaches: affinity purification
coupled to mass spectrometry analysis (AP-MS) and the yeast two-
hybrid assay (Y2H). Here, we focus on the characterization of one
of our RBPJ proteomic hits: L3MBTL3 (also known as MBT1).
L3MBTL3 [lethal (3) malignant brain tumor-like 3] is a poorly char-
acterized member of the MBT (malignant brain tumor) family of
methyl-lysine readers that act as chromatin-interacting transcrip-
tional repressors (Bonasio et al, 2010; Nady et al, 2012). In the case
of L3MBTL1, a paralog of L3MBTL3, its MBT domains promote
binding to methyl-lysines within histone proteins (Min et al, 2007;
Nady et al, 2012), leading to chromatin compaction and repression
(Trojer et al, 2007), or within non-histone proteins, for example,
p53 (West et al, 2010). L3MBTL3 contains three MBT domains,
whose functions remain to be characterized. In mice, loss of
L3MBTL3 leads to impaired maturation of myeloid progenitors caus-
ing the L3MBTL3/ mice to die of anemia at a late embryonic stage
(E18) (Arai & Miyazaki, 2005).
In this report, we show that L3MBTL3 physically and function-
ally interacts with RBPJ. L3MBTL3 co-localizes with RBPJ on chro-
matin and contributes to the recruitment of the histone demethylase
KDM1A [lysine (K)-specific demethylase 1A, also known as LSD1]
at Notch target genes, thus resulting in their transcriptional repres-
sion. Finally, the genetic analyses of the homologs of RBPJ and
L3MBTL3 in Drosophila and C. elegans suggest that the functional




To identify novel RBPJ interactors, we performed a proteomic
screen and obtained multiple independent lines of evidence support-
ing a molecular interaction between RBPJ and L3MBTL3. First, we
identified the RBPJ/L3MBTL3 interaction in a Y2H proteomic screen
(Fig 1A). Second, we performed duplicate AP-MS experiments for
HA-tagged RBPJ in U87-MG cells. The MS analysis of the purified
protein extracts unveiled: (i) the successful purification of HA-RBPJ
with 169 and 494 MS spectra matching the RBPJ protein sequence
in the AP-MS experiments #1 and #2, respectively; (ii) the co-purifi-
cation of previously known RBPJ interactors, for example, NOTCH2,
MINT, and KYOT2 (Taniguchi et al, 1998; Oswald et al, 2002); and
(iii) the co-purification of endogenous L3MBTL3, with six and 17
MS spectra matching L3MBTL3 protein sequence in AP-MS experi-
ments #1 and #2, respectively (Table EV1). In a reciprocal AP-MS
experiment using HA-tagged L3MBTL3 as a bait, 124 MS spectra
matching L3MBTL3 protein sequence were observed, validating the
successful purification of HA-L3MBTL3. In addition, three MS spec-
tra matching RBPJ protein sequence were observed in this L3MBTL3
AP-MS experiment (Table EV1), further supporting the Y2H data.
Next, we performed immuno-precipitations (IPs) of HA-tagged
RBPJ or HA-tagged L3MBTL3 in U87-MG cells followed by Western
blot analyses using RBPJ or L3MBTL3 antibody. We observed that
endogenous L3MBTL3 co-purifies with HA-RBPJ and that endoge-
nous RBPJ co-purifies with HA-L3MBTL3 (Fig 1B and C). In support
of our data, the RBPJ/L3MBTL3 interaction was also recently
uncovered in a large-scale proteomic analysis, using a tandem AP-
MS approach in HEK293T cells (Li et al, 2015b). We further vali-
dated the RBPJ/L3MBTL3 interaction by performing reciprocal IPs
in HEK293T cells in which HA-tagged RBPJ and MYC-tagged or
SBP-FLAG-tagged L3MBTL3 were co-expressed (Appendix Fig S1A).
Finally, we performed GST pulldowns with bacteria-purified RBPJ
and in vitro-transcribed/translated L3MBTL3 proteins (Appendix
Fig S1B–D). The results of these GST pulldown experiments validate
the RBPJ/L3MBTL3 interaction and demonstrate a direct interac-
tion, as suggested by the Y2H experiment (Appendix Fig S1B and
C). In addition, dividing the L3MBTL3 protein in two partially over-
lapping fragments, we observed that the RBPJ/L3MBTL3 interaction
is mediated by a domain located in the N-terminal end of L3MBTL3
(Appendix Fig S1B and D). Altogether, these data demonstrate the
direct RBPJ/L3MBTL3 interaction.
Mapping the RBPJ/L3MBTL3 interaction
As a first step toward the characterization of the molecular interplay
between RBPJ and L3MBTL3, a series of L3MBTL3 deletion mutants
were employed to identify its RBPJ-interacting domain(s) (Fig 2A).
In IP experiments, we observed that the MBT, ZnF, and SAM
domains are not required for the RBPJ/L3MBTL3 interaction
(Fig 2B). In contrast, we observed that the deletion of the
L3MBTL3-(1-64) domain strongly impairs the interaction with RBPJ,
supporting an important role for this domain in the mediation of the
RBPJ/L3MBTL3 interaction (Fig 2B).
Similarly, we tested various mutants of RBPJ for their ability to
interact with L3MBTL3 (Fig 2C). We observed that the N-terminal
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Figure 1. RBPJ interacts with L3MBTL3.
A Detection of the RBPJ/L3MBTL3 interaction using the yeast two-hybrid (Y2H) assay. In this Y2H experiment, RBPJ is fused to the GAL4 DNA-binding (DB) domain and
L3MBTL3 is fused to the GAL4 activation domain (AD). The DB-RBPJ and AD-L3MBTL3 fusion proteins interact with each other, leading to the activation of the ADE2
and HIS3 reporter genes and allowing yeast cells to grow on selective media lacking adenine or histidine. The six Y2H controls were previously described (Dreze et al,
2010). The experiment was independently replicated thrice.
B Endogenous L3MBTL3 co-purifies specifically with HA-RBPJ but not with HA-EGFP, HA-TBL1X, or HA-HEY2. Immuno-precipitation (IP) of HA-tagged RBPJ, EGFP, TBL1X,
or HEY2 in U87-MG cells followed by Western blot analyses using HA or L3MBTL3 antibody. The experiment was independently replicated twice.
C Endogenous RBPJ co-purifies specifically with HA-L3MBTL3 but not with HA-EGFP, HA-TBL1X, or HA-HEY2. IPs of HA-tagged L3MBTL3, EGFP, TBL1X, or HEY2 in U87-
MG cells followed by Western blot analyses using HA or RBPJ antibody. The experiment was independently replicated twice.
Data information: EV, empty vector control; WB, Western blot; IP, immuno-precipitation.
Source data are available online for this figure.
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domain (NTD) and C-terminal domain (CTD) of RBPJ are not
required for the L3MBTL3 interaction (Fig 2D). In contrast, we
observed that the absence of the b-trefoil domain (BTD) strongly
impairs the RBPJ/L3MBTL3 interaction (Fig 2D). As we narrowed
down our analysis to single missense mutants, we identified three
L3MBTL3 interaction-defective mutants of RBPJ: RBPJF261R,
RBPJV263R, and RBPJA284R (Fig 2E). Interestingly, the F261, V263,
and A284 residues are located in the BTD domain and are also
required for the RBPJ/NOTCH ICD interaction (Yuan et al, 2012).
These observations suggest a molecular model in which NOTCH
ICD and L3MBTL3 bind to the same interaction interface in the BTD
domain and may therefore compete for binding to RBPJ.
Thermodynamic analysis of the RBPJ/L3MBTL3 interaction
To estimate the thermodynamic binding parameters that underlie
the RBPJ/L3MBTL3 interaction, we used isothermal titration
calorimetry (ITC) with highly purified preparations of recombinant
RBPJ and L3MBTL3 proteins (Fig 3A and Table 1). The L3MBTL3-
(31-70) domain mediates a 1:1 interaction with RBPJ that is charac-
terized by a moderate binding affinity (Kd = 0.45 lM). These data
suggest that, under cell-free settings, the N-terminal region of
L3MBTL3 supports the interaction with RBPJ. The affinity between
RBPJ and L3MBTL3 is stronger than the one previously measured,
under identical conditions, between RBPJ and the viral co-activator
EBNA2 (Kd = 4.6 lM) (Johnson et al, 2010). However, the binding
affinity of the RBPJ/L3MBTL3 interaction is weaker than the ones
observed for the RBPJ interactors NOTCH ICD-RAM (Kd = 22 nM)
(Friedmann et al, 2008), KyoT2 (Kd = 12 nM) (Collins et al, 2014)
and MINT (Kd = 11 nM) (VanderWielen et al, 2011).
If, as suggested by the results of our mapping experiments (Fig 2D
and E), NOTCH ICD competes with L3MBTL3 for binding to RBPJ,
our Kd measurements suggest that NOTCH ICD has a significantly
higher affinity (Fig 3A and Table 1) and would therefore likely
outcompete L3MBTL3 for binding to RBPJ. To verify this hypothesis,
we performed a competition IP assay in which the RBPJ/L3MBTL3
interaction is tested in the presence of an increasing amount of
NOTCH1 ICD. As shown in Fig 3B, the RBPJ/L3MBTL3 interaction is
strongly impaired in the presence of NOTCH1 ICD in a dose-depen-
dent manner. We note that an approximately equal amount of
NOTCH1 ICD displaces most L3MBTL3 molecules from RBPJ
complexes (Fig 3B) but that the reciprocal is not observed, that is,
L3MBTL3 does not displace NOTCH1 ICD from RBPJ (Fig 3C),
corroborating the results of our ITC experiment, that is, L3MBTL3
binds to RBPJ with a moderate affinity (Kd = 0.45 lM), which is
about 20-fold weaker than the one previously observed for the RBPJ/
NOTCH ICD interaction (Kd = 22 nM) (Friedmann et al, 2008).
L3MBTL3 acts as a negative regulator of Notch target genes
RBPJ has a dual role in the regulation of Notch signaling, that is,
depending on the cell context, depletion of RBPJ can result either in
the inhibition or in the activation (“de-repression”) of Notch target
genes. In U87-MG cells, where Notch signaling tone is low
(Appendix Fig S2), we observed that the depletion of RBPJ results in
the upregulation of the Notch target genes HES1, HES4, HEY1, and
HEY2 (Fig 4A), suggesting that RBPJ protein complexes are actively
involved in the repression of Notch target genes in this context. As a
RBPJ co-factor, L3MBTL3 may also contribute to the RBPJ-mediated
repression of Notch target genes in U87-MG cells. To test this
hypothesis, we evaluated the effects of depletion of L3MBTL3 on
gene expression. As shown in Fig 4B, the CRISPR/Cas9-mediated
loss of L3MBTL3 leads to upregulation of HES1, HES4, HEY1, and
HEY2, suggesting that L3MBTL3 actively contributes to the repres-
sion of Notch target genes in U87-MG cells.
We hypothesized that L3MBTL3 forms a chromatin-bound
complex with RBPJ at the Notch-responsive elements of Notch
target genes to repress their expression. To test this hypothesis, we
performed chromatin immuno-precipitation (ChIP) experiments in
U87-MG cells to determine whether L3MBTL3 localizes at the RBPJ-
bound Notch-responsive elements of HES1, HES4, HEY1, and HEY2
(either proximal or distal to the promoter; represented in
Appendix Fig S3A). Our results indicate that L3MBTL3 co-localizes
with RBPJ at the Notch-responsive elements of these Notch target
genes (Fig 4C and Appendix Fig S3B and C). To investigate the RBPJ
dependence of L3MBTL3 binding at these sites, we performed ChIP
in U87-MG cells in the presence (sh-Scramble control cells, or “sh-
Scr”) or absence (sh-RBPJ RNAi-mediated knockdown) of RBPJ. We
observed that the depletion of RBPJ results in a strong reduction of
L3MBTL3 occupancy at the proximal Notch-responsive elements of
Notch target genes (Fig 4D). We note that the reciprocal was not
observed, as the knockout (KO) of L3MBTL3 has no effect on the
binding of RBPJ (Appendix Fig S3D).
To further investigate the extent to which L3MBTL3’s ability to
regulate Notch signaling directly depends on the presence of RBPJ,
we analyzed the expression of Notch target genes in U87-MG cells in
▸Figure 2. Mapping of the RBPJ/L3MBTL3 interaction.A Schematic representation of the L3MBTL3 protein and the deletion mutants used in panel (B). The L3MBTL3 protein (XP_006715641.1) consists of a C2C2 zinc finger
(ZnF #1; CDD: 128717), three MBT domains (CDD: 214723), a C2H2 zinc finger (ZnF #2; CDD: 201844), and a sterile a motif domain (SAM; CDD: 197735).
B L3MBTL3-D(1-64) does not interact with RBPJ. IP of HA-FLAG-tagged RBPJ in the presence of FLAG-tagged L3MBTL3 (WT or deletion mutants) in HEK293T cells
followed by Western blotting using FLAG antibody. The experiment was independently replicated twice.
C Schematic representation of the RBPJ protein and the deletion mutants used in panels (D and E). The RBPJ protein (XP_005248218.1) consists of the N-terminal
domain (NTD), the b-trefoil domain (BTD), and the C-terminal domain (CTD).
D Deletion of the BTD domain impairs the RBPJ/L3MBTL3 interaction. IP of HA-tagged L3MBTL3 in the presence of FLAG-tagged RBPJ (WT and deletion mutants) in
HEK293T cells followed by Western blotting using HA or FLAG antibody. The experiment was independently replicated twice.
E RBPJF261R point mutant does not interact with L3MBTL3. IP of HA-tagged L3MBTL3 in the presence of FLAG-tagged RBPJ (WT and point mutants) in HEK293T cells
followed by Western blotting using HA or FLAG antibody. RBPJV263R and RBPJA284R also show a reduced ability to interact with L3MBTL3. The experiment was
independently replicated twice.
Data information: WB, Western blot; IP, immuno-precipitation.
Source data are available online for this figure.
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the presence (sh-Scr) or absence of RBPJ (sh-RBPJ), upon overexpres-
sion of L3MBTL3 (Fig 4E, and Appendix Fig S3E and F). In RBPJ
competent cells (sh-Scr), the overexpression of L3MBTL3 leads to the
strong downregulation of the HES1 and HEY2 Notch target genes (86
and 52% downregulation, respectively). In contrast, in RBPJ-defi-
cient cells (sh-RBPJ), the overexpression of L3MBTL3 has only a mild
effect on the expression of HES1 and HEY2 (53 and 21% downregula-
tion, respectively; Fig 4E). These data demonstrate the RBPJ-depen-
dent role of L3MBTL3 in the repression of Notch target genes.
To assess the extent to which L3MBTL3’s ability to co-localize
with RBPJ on chromatin depends on the mediation of the RBPJ/
L3MBTL3 interaction by the L3MBTL3-(1-64) domain, we performed
ChIP experiments to investigate chromatin binding by HA-L3MBTL3
and HA-L3MBTL3-D(1-64) in U87-MG cells. We observed that the
occupancy of L3MBTL3 at the proximal Notch-responsive elements
of Notch target genes is reduced in the absence of the RBPJ-inter-
acting domain L3MBTL3-(1-64) (Fig 4F). Next, we tested the ability
of both L3MBTL3 wild type (WT) and L3MBTL3-D(1-64) to repress
Notch target genes in U87-MG cells. We observed that overexpres-
sion of L3MBTL3 WT downregulates some of the Notch target genes
under investigation (HES1 and HEY2), validating the active role of
L3MBTL3 in the repression of Notch signaling (Fig 4G). We note
that the absence of effects on the expression of HES4 and HEY1 can
be due to the presence of endogenous L3MBTL3 and the fact that
these genes are already actively repressed. In contrast, not only does
L3MBTL3-D(1-64) have no repressive effect on Notch target genes,
but also its overexpression actually leads to their upregulation
(Fig 4G). Thus, L3MBTL3-D(1-64) has a dominant negative effect on
endogenous L3MBTL3’s ability to repress Notch target genes. We
hypothesized that this effect could be due to the “sequestration” by
L3MBTL3-D(1-64) of co-factors that are essential for endogenous
L3MBTL3 to mediate its repressive effect on Notch signaling. In the
next section, we describe one such putative co-factor, KDM1A.
To validate these observations in another cell context, we tested
L3MBTL3’s ability to bind chromatin at the Notch-responsive
elements of Notch target genes and to modulate their expression in
MDA-MB-231, a human breast cancer cell line with low Notch activ-
ity (Appendix Fig S4A and B) where depletion of RBPJ results in the
de-repression of Notch target genes [Appendix Fig S4C and (Kulic
et al, 2015)]. In line with our observations in U87-MG cells, we
A B
C
Figure 3. NOTCH1 ICD and L3MBTL3 compete for binding to RBPJ.
A Thermodynamic characterization of the RBPJ/L3MBTL3 interaction. Representative thermograms (raw heat signal and nonlinear least squares fit to the integrated
data) for L3MBTL3-(31-70) binding to RBPJ-(53-474).
B, C NOTCH1 ICD outcompetes L3MBTL3 for binding to RBPJ in a dose-dependent manner. IPs were performed in CRISPR/Cas9-mediated L3MBTL3 knockout (KO)
HEK293T cells. (B) SBP-FLAG-RBPJ and HA-L3MBTL3-D(SAM) in the presence of an increasing amount of HA-NOTCH1 ICD. (C) SBP-FLAG-RBPJ and HA-NOTCH1 ICD in
the presence of an increasing amount of HA-L3MBTL3-D(SAM). The L3MBTL3-D(SAM) mutant construct was used instead of the L3MBTL3 WT construct in order to
allow the analysis of both NOTCH1 ICD and L3MBTL3 proteins in the same Western blot. CRISPR/Cas9 sg-L3MBTL3-resistant plasmids were used to express HA-
L3MBTL3-D(SAM). The experiment was independently replicated thrice. WB, Western blot; IP, immuno-precipitation.
Source data are available online for this figure.
Table 1. Thermodynamic characterization of the RBPJ/L3MBTL3 interaction.
Macromolecule Ligand K (M1) Kd (lM) DG° (kcal/mol) DH° (kcal/mol) TDS° (kcal/mol)
RBPJ-(53-474) L3MBTL3-(31-70) 2.27  0.34 × 106 0.45  0.06 8.66  0.08 7.52  0.75 1.14  0.84
Calorimetric data for the binding of L3MBTL3-(31-70) to RBPJ-(53-474). All experiments were performed at 25°C. Shown are means  s.d. of triplicate experiments.
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observed the following (i) depletion of L3MBTL3 leads to the de-
repression of Notch target genes (Appendix Fig S4C); (ii) analysis of
L3MBTL3 and RBPJ by ChIP-seq revealed a substantial and signifi-
cant genomewide co-localization on chromatin (P < 4 × 1057; two-
sided Fisher exact test; Fig EV1A); (iii) genes bound by L3MBTL3
are enriched for genes associated with both the GO terms “Notch
pathway genes” (P = 4 × 104) and “Notch-mediated HES/HEY
network” (P = 6 × 105); (iv) L3MBTL3 co-localizes with RBPJ at
the Notch-responsive elements of Notch target genes, for example,
HES1 and HEY2 (Fig EV1B, and Appendix Fig S4D and E); (v)
L3MBTL3 occupancy at the proximal Notch-responsive elements is
RBPJ dependent (Appendix Fig S4E); (iii) L3MBTL3 represses Notch
target genes in a RBPJ-dependent manner (Appendix Fig S4F); (iv)
L3MBTL3’s ability to bind chromatin requires the presence of the
RBPJ-interacting domain L3MBTL3-(1-64) (Appendix Fig S4G); and
(v) L3MBTL3 repressive activity on Notch target genes is dependent
on the L3MBTL3-(1-64) domain (Appendix Fig S4H). Similarly, in a
clonal mouse hybridoma mature T-cell line, which is characterized
by low Notch activity (Appendix Fig S5A–C), depletion of L3MBTL3
leads to the de-repression of Notch target genes (Appendix Fig S5D
and E). Altogether, these data strongly support a role for L3MBTL3
in the RBPJ-dependent repression of Notch target genes in mamma-
lian cells. Finally, in agreement with the observation that NOTCH1
ICD outcompetes L3MBTL3 for binding to RBPJ (Fig 3B and C), we
note that de-repression of Notch target genes is not observed upon
L3mbtl3 knockdown in Beko cells, a mouse pre-T-cell line that is
characterized by a high level of cleaved NOTCH1 ICD (Liefke et al,
2010) (Appendix Fig S5A and F).
L3MBTL3 interacts with KDM1A
L3MBTL3-D(1-64), the RBPJ interaction-defective mutant, has a
dominant negative effect on endogenous L3MBTL3’s ability to
repress Notch target genes (Fig 4G and Appendix Fig S4H). We
hypothesized that this effect could be due to the “sequestration” by
L3MBTL3-D(1-64) of co-factors that are essential for endogenous
L3MBTL3 to mediate its repressive effect on gene expression.
L3MBTL3 is poorly characterized at the molecular level. To identify
co-factors that may be recruited by L3MBTL3 to RBPJ-bound enhan-
cers, we screened L3MBTL3 using our proteomic pipeline. We
obtained multiple, independent lines of evidence supporting a
molecular interaction between L3MBTL3 and KDM1A. First, we
identified the L3MBTL3/KDM1A interaction in a Y2H screen
(Fig EV2A). Second, we performed IP of endogenous RBPJ in U87-
MG or MDA-MB-231 cells followed by Western blot analyses using
KDM1A, L3MBTL3, or RBPJ antibody. We observed that endoge-
nous RBPJ interacts with both endogenous KDM1A and endogenous
L3MBTL3 (Fig EV2B). Third, we performed IP of V5-tagged
L3MBTL3 or L3MBTL3-D(1-64) in U87-MG cells followed by
Western blot analysis using a KDM1A antibody. We observed that
endogenous KDM1A interacts with both the WT and mutant
proteins (Fig EV2C).
KDM1A [lysine (K)-specific demethylase 1A] is a histone
demethylase (Shi et al, 2004), which associates with different protein
complexes on chromatin. Depending of the cell context, KDM1A can
demethylate either the positive H3K4me1/me2 (Shi et al, 2004) or
the negative H3K9me1/me2 (Metzger et al, 2005) marks and, as
such, it can support either transcriptional repression or activation,
respectively (Amente et al, 2013). The demethylase activity of this
enzyme plays an important role in a large variety of biological
processes, including development and cancer (Amente et al, 2013).
Previous reports have described RBPJ-dependent recruitment of
KDM1A to chromatin as an important mechanism to modulate Notch
signaling in various cell contexts (Wang et al, 2007; Mulligan et al,
2011; Yatim et al, 2012). Interestingly, we observed that KDM1A also
interacts with RBPJ in U87-MG cells (Fig EV2D and E).
We hypothesized that L3MBTL3 plays an essential role in the
recruitment of KDM1A to RBPJ-repressor complexes. To test this
hypothesis, we investigated whether the RBPJ/KDM1A interaction
could be regulated in an L3MBTL3-dependent manner. In reciprocal
IP experiments, we observed that both L3MBTL3 WT and
L3MBTL3-D(1-64), the RBPJ interaction-defective mutant, co-purify
with KDM1A (Figs 5A and EV2C). In the absence of L3MBTL3, the
RBPJ/KDM1A interaction is weak (lane #5 in Fig 5A). Remarkably,
the RBPJ/KDM1A interaction is “rescued” in the presence of
L3MBTL3 WT (lane #4) but only partially rescued in the presence of
▸Figure 4. RBPJ recruits L3MBTL3 on chromatin to repress the expression of Notch target genes in U87-MG cells.A De-repression of Notch target genes upon RBPJ knockdown. Shown are means  s.d. of quadruplicate experiments. *P < 0.05, **P < 0.01, NS, not significant; one-way
ANOVA model on log-transformed data. Inset: Western blot analysis validates the shRNA-mediated depletion of RBPJ.
B De-repression of Notch target genes in L3MBTL3 KO U87-MG cells. Shown are means  s.d. of quadruplicate experiments. **P < 0.01, NS, not significant; two-sample
t-test on log-transformed data. Inset: Western blot analysis validates the CRISPR/Cas9-mediated KO of L3MBTL3.
C RBPJ and L3MBTL3 co-localize at the proximal Notch-responsive elements of Notch target genes. Shown are means  s.d. of triplicate ChIP experiments.
D L3MBTL3 occupancy at the proximal Notch-responsive elements of Notch target genes decreases upon RBPJ knockdown. Shown are means  s.d. of triplicate ChIP
experiments.
E The repressive activity of L3MBTL3 at Notch target genes is RBPJ dependent. Expression analysis of Notch target genes upon RBPJ knockdown and/or overexpression of
L3MBTL3. Shown are means  s.d. of triplicate experiments. P-values were estimated via a one-way ANOVA model on log-transformed data where the difference of
differences was tested, which is equivalent to testing the interaction in a two-way ANOVA model. Western blot analysis validates the overexpression of L3MBTL3 and
the shRNA-mediated depletion of RBPJ (Appendix Fig S3E). Gene expression analyses of OCT4 was performed as control (Appendix Fig S3F).
F L3MBTL3 occupancy at the proximal Notch-responsive elements of Notch target genes is dependent on its RBPJ-interacting domain. ChIP analyses of HA-L3MBTL3 WT
and HA-L3MBTL3-D(1-64) occupancy at the proximal Notch-responsive elements of Notch target genes. Shown are means  s.d. of duplicate experiments measured
twice each.
G The L3MBTL3-(1-64) domain is required for the downregulation of HES1 and HEY2 in U87-MG cells. Expression analysis of Notch target genes upon overexpression of
L3MBTL3 WT, L3MBTL3-D(1-64), or LacZ control (Control). Shown are means  s.d. of triplicate experiments. *P < 0.05, **P < 0.01, NS, not significant; one-way
ANOVA model on log-transformed data.
Data information: In panels (C, D, and F): distance in base pairs (bp) relative to the transcriptional start site (TSS) is indicated below the gene names. Chrom8 was used
as negative control (NEG).
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L3MBTL3-D(1-64) (lane #6), suggesting that the previously reported
RBPJ/KDM1A interaction is indirect and occurs via L3MBTL3.
L3MBTL3 recruits KDM1A at RBPJ-bound sites
We hypothesized that L3MBTL3 mediates the recruitment of
KDM1A to RBPJ-bound sites. To test this hypothesis, we investi-
gated KDM1A occupancy at the Notch-responsive elements of Notch
target genes in L3MBTL3 KO U87-MG cells by ChIP. We observed
that KDM1A occupancy is strongly reduced at the proximal Notch-
responsive elements of Notch target genes in the absence of
L3MBTL3 (Fig 5B). The L3MBTL3-dependent KDM1A occupancy at
these sites can be efficiently rescued by overexpression of L3MBTL3
WT (Fig 5C). In contrast, upon overexpression of either L3MBTL3-D
(1-64), the RBPJ interaction-defective mutant (Fig 2B), or L3MBTL3-
D(SAM), a KDM1A interaction-defective mutant (Fig EV2F), KDM1A
occupancy at these proximal Notch-responsive elements remains
partially [L3MBTL3-D(1-64)] or completely [L3MBTL3-D(SAM)]
impaired (Fig 5C). Altogether, our results demonstrate that
L3MBTL3 links KDM1A to RBPJ at Notch-responsive elements.
L3MBTL3 represses Notch target genes via KDM1A
Methylation of H3K4 is linked to transcriptional activation (Noma
et al, 2001). Yatim et al (2012) previously described that KDM1A
contributes to the RBPJ-mediated repression of Notch target genes
via demethylation of H3K4me2 in U937, a myeloid cell line charac-
terized by low Notch signaling tone. Similarly, in U87-MG cells, we
observed that de-repression of Notch target genes upon RBPJ knock-
down (Fig 4A) is associated with a significant increase in H3K4me2
(Appendix Fig S6A). We hypothesized that L3MBTL3 represses
Notch target genes by promoting the KDM1A-mediated demethyla-
tion of H3K4me2. To test this hypothesis, we performed gene
expression and ChIP analyses of the well-characterized Notch target
gene HES1 upon overexpression of L3MBTL3WT, L3MBTL3-D(1-64),
or L3MBTL3-D(SAM). We observed that H3K4me2 decreases
considerably upon overexpression of L3MBTL3 WT (Fig 5D and
Appendix Fig S6B). In contrast, H3K4me2 remains stable upon
overexpression of L3MBTL3-D(1-64) and decreases more mildly
upon overexpression of L3MBTL3-D(SAM) (Fig 5D). Accordingly,
the expression of HES1 decreases considerably upon overexpres-
sion of L3MBTL3 WT but not of either L3MBTL3-D(1-64) or
L3MBTL3-D(SAM) (Fig 5E). Thus, L3MBTL3 promotes the repres-
sion of HES1 via KDM1A-mediated demethylation of H3K4me2.
dL(3)mbt genetically interacts with Notch in Drosophila
Drosophila is the model system of choice to study Notch signaling
in vivo (Kopan & Ilagan, 2009; Guruharsha et al, 2012). In Droso-
phila, the Notch pathway governs numerous cell fate decisions
throughout morphogenesis (Bray, 2006; Guruharsha et al, 2012)
and it has a profound effect on many aspects of nervous system
development, including the formation of neuroblasts from neuroep-
ithelial cells (Egger et al, 2010; Reddy et al, 2010; Yasugi et al,
2010). Interestingly, dL(3)mbt, the fly homolog of the human
L3MBTL3 gene, was originally discovered in Drosophila where it
behaves as a suppressor of brain tumorigenesis in the larval optic
lobe (Wismar et al, 1995; Richter et al, 2011). Moreover, in a
combined ex vivo and in vivo RNAi screen for Notch regulators in
Drosophila, the RNAi-mediated knockdown of dL(3)mbt leads to the
upregulation of Notch signaling (Saj et al, 2010). These observa-
tions support the hypothesis of a functional link between the Notch
pathway and dL(3)mbt in Drosophila.
We sought to further investigate the interaction between the
Notch pathway and dL(3)mbt using a combination of computa-
tional, molecular, and genetic approaches (Figs 6, and EV3 and
EV4, and Appendix Figs S7–S12). Using a hidden Markov model
(HMM) approach to detect protein homology (Soding, 2005), HMM
profile–profile alignment analyses identified a conserved region
between the RBPJ-interacting domain L3MBTL3-(1-64) (exact amino
acid position of the conserved region is Q11-N50) and a region of
the Drosophila dL(3)mbt protein (amino acid position S658-Q698)
(P = 6 × 1019; Fig EV3). Accordingly, in a GST pulldown assay, we
observed that dL(3)mbt directly interacts with Su(H), the Drosophila
homolog of RBPJ (Fig 6A). Furthermore, the analysis of previously
published ChIP-chip and ChIP-seq data for Su(H) (Zacharioudaki
▸Figure 5. L3MBTL3 recruits KDM1A at RBPJ-bound Notch-responsive elements to repress Notch target genes.A The RBPJ/KDM1A interaction is indirect and occurs via L3MBTL3. IP of HA-KDM1A in the presence of overexpressed V5-L3MBTL3 or V5-L3MBTL3-D(1-64) in L3MBTL3 KO
U87-MG cells. CRISPR/Cas9 sg-L3MBTL3-resistant plasmids were used to overexpress the L3MBTL3 proteins. The experiment was independently replicated twice.
B KDM1A occupancy at the proximal Notch-responsive elements of Notch target genes is L3MBTL3 dependent. ChIP analysis of endogenous KDM1A in L3MBTL3 KO
U87-MG cells. Shown are means  s.d. of duplicate experiments measured twice each.
C KDM1A occupancy at the proximal Notch-responsive elements of Notch target genes is dependent on L3MBTL3, and both its RBPJ interaction and KDM1A interaction
domains. ChIP analysis of endogenous KDM1A in L3MBTL3 KO U87-MG cells upon overexpression of L3MBTL3, L3MBTL3-D(1-64) or L3MBTL3-D(SAM). Control: empty
vector. Shown are means  s.d. of duplicate experiments measured twice each.
D L3MBTL3, but neither L3MBTL3-D(1-64) nor L3MBTL3-D(SAM), leads to decreasing H3K4me2 at the proximal Notch-responsive element of HES1. ChIP analysis of
H3K4me2 at the proximal Notch-responsive element of HES1 upon overexpression of LacZ control (Control), L3MBTL3, L3MBTL3-D(1-64), or L3MBTL3-D(SAM) in
L3MBTL3 KO U87-MG cells. Shown are means  s.d. of duplicate experiments measured twice each. P-values were estimated via a one-way ANOVA on log-
transformed data.
E L3MBTL3, but neither L3MBTL3-D(1-64) nor L3MBTL3-D(SAM), represses HES1. Expression analysis of HES1 upon overexpression of LacZ control (Control), L3MBTL3,
L3MBTL3-D(1-64), or L3MBTL3-D(SAM) mutants in L3MBTL3 KO U87-MG cells. Shown are means  s.d. of triplicate experiments. P-values were estimated via a one-
way ANOVA on log-transformed data. NS, not significant. WB, Western blot; IP, immuno-precipitation. We note that in the context of this experiment, that is, in the
absence of endogenous L3MBTL3, the overexpression of L3MBTL3-D(1-64) does not result in the increased expression of HES1, contrasting with the result obtained in
Fig 4G, that is, in the presence of endogenous L3MBTL3. Indeed, as expected, the dominant negative effect of L3MBTL3-(1-64) on endogenous WT L3MBTL3’s ability to
repress the expression of Notch target genes can only be observed when WT L3MBTL3 is expressed.
Data information: Panels (B–D): distance in bp relative to the TSS is indicated below the gene names. Chrom8 was used as negative control (NEG).
Source data are available online for this figure.
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et al, 2016) and dL(3)mbt (Li et al, 2015a) revealed a substantial
and significant genomewide co-localization of the proteins under
investigation (P < 1 × 1031; two-sided Fisher exact test; Fig 6B).
Among the co-bound sites, we note the presence of “classical”
Drosophila Notch targets, for example, the E(spl) locus, lola, and
dNotch itself (Fig 6C and Appendix Fig S7). In a complementary
analysis of mRNA expression and in agreement with the observation
that the RNAi-mediated knockdown of dL(3)mbt leads to the upreg-
ulation of Notch signaling (Saj et al, 2010), we observed that genes
identified as upregulated in brain tumors upon dL(3)mbt KO (Janic
et al, 2010) overlap with genes identified as upregulated in brain
tumors upon sustained NICD expression (Zacharioudaki et al, 2016)
(P = 0.01; two-sided Fisher exact test), indicating that both types of
brain tumors share a common expression signature.
To investigate the in vivo relevance of the Su(H)/dL(3)mbt
interaction, we examined the functional cross talk between the
Notch pathway and dL(3)mbt in various Drosophila tissues. First,
we observed that the E(spl)mc-HLH-GFP reporter is upregulated
in larval brain tumors induced by loss of dL(3)mbt
(Appendix Fig S8). Second, expression of dL(3)mbt suppresses
dNICD-induced hyperplasia in the eye imaginal disk (Fig EV4).
Accordingly, the combined loss of function of dL(3)mbt and gain
of function of dNICD synergize to promote hyperplasia in the
eye imaginal disk (Appendix Fig S9). The disk cells at the
dorsal–ventral compartment border generate the wing margin,
and loss of wing margin cells (wing notching) is one of the
characteristic phenotypes associated with loss of Notch signaling,
for example, Notch haploinsufficiency (Morgan, 1917). Remark-
ably, we observed that the exogenous expression of dL(3)mbt is
not only associated with the repression of the Notch target gene
cut in the wing disk (Fig 6D and Appendix Figs S10–S12), and it
also results in the classic wing notching phenotype in adult flies
(Fig 6E). Altogether, these data suggest that dL(3)mbt is a bona
fide regulator of the Notch pathway and underscore a striking
conservation of the Notch pathway/L3MBTL3 interaction from
insects to mammals.
lag-1 genetically interacts with lin-61 in Caenorhabditis elegans
Genetic analysis of Notch signaling in C. elegans has illuminated
universal aspects of this essential and conserved pathway
(Greenwald, 2012), for example, establishing the requirement of the
c-secretase complex for Notch signal activation (Levitan & Green-
wald, 1995). To further explore the functional relevance of the/
L3MBTL3 interaction across species, we sought to investigate the
functional link between lag-1 and lin-61, the C. elegans homologs
of RBPJ and L3MBTL3 genes, respectively. The role of Notch
signaling in mediating cell–cell interactions is essential throughout
C. elegans morphogenesis and is particularly well documented in
embryonic (Priess, 2005) and vulva development (Gupta et al,
2012). Interestingly, independent genetic and expression studies
have linked both lag-1 and lin-61 to both these developmental
processes (Qiao et al, 1995; Rual et al, 2004; Harrison et al, 2007).
These observations prompted us to investigate the functional cross
talk between lag-1 and lin-61 during embryogenesis and vulva
development.
During embryogenesis, a proportion of the lag-1(om13) ther-
mosensitive mutant embryos fail to develop and do not hatch (Qiao
et al, 1995). In N2 animals (N2 refers to the WT strain), we
observed that the RNAi-induced inactivation of lin-61 has no inci-
dence on embryonic lethality (Fig EV5). In contrast, in lag-1(om13)
animals, lin-61(RNAi) results in a twofold increase of embryonic
lethality from 27 to 51%, thus demonstrating a genetic interaction
between lag-1 and lin-61 during C. elegans embryonic development
(Fig EV5). Furthermore, during vulva development, we observed
that ~19% of lag-1(RNAi) animals and ~11% of lin-61(n3809)
mutants present a protruding vulva phenotype (Pvl), compared to
only ~2% for the control (N2) animals. Interestingly, the combined
inactivation of lag-1 and lin-61 [lag-1(RNAi); lin-61(n3809)]
resulted in a synergistic effect, that is, 52% of the animals show a
Pvl phenotype, indicating a functional interaction between lag-1 and
lin-61 (Fig 6F). Remarkably, a functional link between RBPJ/Su(H)/
lag-1 and L3MBTL3/dL(3)mbt/lin-61 (human/fly/worm) is thus
conserved across metazoan species (Figs 6 and EV3–EV5, and
Appendix Figs S7–S12).
Discussion
Our molecular studies demonstrate a direct, physical interaction
between RBPJ and L3MBTL3. Our mapping and thermodynamic
studies revealed that the interaction is mediated by the L3MBTL3-
(31-70) and the RBPJ-BTD domains with a 450 nM binding affinity.
The RBPJ-BTD domain also interacts with the NOTCH ICD-RAM
▸Figure 6. The interaction between RBPJ/Su(H)/lag-1 and L3MBTL3/dL(3)mbt/lin-61 is evolutionarily conserved.A GST pulldown showing that dL(3)mbt, the Drosophila homolog of L3MBTL3, directly interacts with Su(H), the Drosophila homolog of RBPJ. In vitro-transcribed and
translated dL(3)mbt or dNotch ICD (dNotch ICD fragment containing the RAM domain and ANK repeats), as positive control, was incubated with bacterially purified
GST-Su(H) or GST alone pre-bound to GSH beads. Proteins were resolved via SDS–PAGE and signals were acquired via X-ray exposure. The experiment was
independently replicated four times.
B dL(3)mbt and Su(H) co-localize genomewide. Venn diagram showing the genomewide co-localization of dL(3)mbt and Su(H).
C Snapshot showing the co-localization of dL(3)mbt and Su(H) at the dNotch (N) locus.
D In the wing imaginal disk, dL(3)mbt overexpression in the dorso–ventral (D-V) boundary results in the downregulation of the Notch target gene cut. Wing disks
expressing UAS-GFP (top panels) or UAS-HA-dL(3)mbt;UAS-GFP (bottom panels) under the vg-Gal4 driver at 25°C were stained for cut and HA. GFP marks the vg-Gal4
expression domain. Insets below each panel show a closer view of the D-V boundary with yellow arrows marking the regions where HA-dL(3)mbt is expressed and cut
is downregulated. At least 20 disks for each genotype were analyzed. Representative images are shown. Scale bars: 100 lm.
E The vg-Gal4-driven HA-dL(3)mbt overexpression causes a serrated wing (wing notching) phenotype. Flies expressing either UAS-GFP or UAS-HA-dL(3)mbt;UAS-GFP
under vg-Gal4 were reared to adulthood at 25°C. P-values were estimated by comparing the proportions via a two-proportion Z-test. Scale bars: 200 lm.
F Functional interaction between lag-1/RBPJ and lin-61/L3MBTL3 during Caenorhabditis elegans vulva development. Proportion of animals (n ≥ 100) displaying a
protruding vulva (Pvl) phenotype after RNAi treatment for two generations. Worms were grown at 25°C. Shown are means  s.d. of duplicate experiments. EV, empty
vector control.
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domain and is required for the formation of the NTC (Kopan &
Ilagan, 2009). As suggested by the moderate binding strength of the
RBPJ/L3MBTL3 interaction, which is 20-fold weaker than the
affinity of the RBPJ/NOTCH ICD-RAM interaction (Friedmann et al,
2008), and by the observation that both L3MBTL3 and NOTCH ICD
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ICD outcompetes L3MBTL3 for binding to RBPJ. Other RBPJ co-
factors, for example, EBNA2 and KyoT2, have been previously
shown to interact with RBPJ through “RAM-like” domains (Ling &
Hayward, 1995; Collins et al, 2014) which, as the NOTCH ICD-RAM
domain, are characterized by a /W/P (/ = hydrophobic) tetrapep-
tide motif (Kovall & Hendrickson, 2004). As observed for the other
RBPJ co-factor MINT, there are no such RAM-like domains detect-
able in the L3MBTL3 amino acid sequence, suggesting that a dif-
ferent interaction motif is involved.
Malignant brain tumor domain-containing proteins have been
linked to transcriptional repression across metazoans (Harrison
et al, 2007; Trojer et al, 2007; Grimm et al, 2009; Bonasio et al,
2010; Richter et al, 2011; Tang et al, 2013), but it remains unclear
how they are recruited to specific regions of the genome. There are
only a few reports where models of recruitment mechanisms have
been proposed (Boccuni et al, 2003; Tang et al, 2013). Is L3MBTL3,
which, of all MBT proteins, appears to have the lowest selectivity
for any particular methylated histone mark (Nady et al, 2012),
bound to chromatin? Our data provide clear support for the RBPJ-
mediated recruitment of L3MBTL3 to chromatin at the Notch-
responsive elements of Notch target genes. The role of the MBT and
ZnF domains in this context remains to be characterized. Finally, in
agreement with the well-documented role of MBT proteins as chro-
matin condensers (Bonasio et al, 2010) and the fact that NOTCH
ICD and L3MBTL3 compete for binding to RBPJ, our expression
analysis of Notch target genes shows that L3MBTL3 is a negative
regulator of Notch signaling in mammalian cells. The observation
that NOTCH ICD displaces L3MBTL3 from RBPJ suggests that the
functional relevance of L3MBTL3 to the regulation of Notch target
genes may be particularly important in cell contexts where the DSL
ligand-dependent activation of Notch and subsequent release of
NOTCH ICD are low or moderate.
The recruitment of KDM1A by RBPJ to chromatin has been previ-
ously linked to the modulation of Notch signaling (Wang et al,
2007; Mulligan et al, 2011; Yatim et al, 2012). We have now
expanded these observations by further dissecting the molecular
mechanism that governs KDM1A recruitment at Notch-responsive
elements. Our results unveil L3MBTL3 as a key molecular link
between RBPJ and KDM1A in RBPJ-repressive complexes and indi-
cate that the repressive role of L3MBTL3 at Notch target genes is
mediated through the KDM1A-dependent demethylation of
H3K4me2. We propose a molecular model in which L3MBTL3
recruits KDM1A at RBPJ-bound sites and promotes the repression of
Notch signals via KDM1A-dependent H3K4me2 demethylation
(Fig 7). Interestingly, L3MBTL3 has the highest affinity toward
dimethylated marks, including H3K4me2, though relatively promis-
cuous (Nady et al, 2012). We speculate that, during the transition of
RBPJ-bound Notch-responsive elements from the “ON” to the “OFF”
state, the preferential binding of L3MBTL3 to H3K4me2 may contri-
bute to the preferential recruitment of KDM1A at sites where
KDM1A’s H3K4me2 demethylase activity is most needed to nega-




Figure 7. Model for the regulation of Notch target genes by L3MBTL3.
A NOTCH ICD binds to RBPJ-bound Notch-responsive elements where it builds up a co-activator complex composed of Mastermind-like 1 (MAML1) and additional co-
activators to induce expression of Notch target genes.
B In the absence of Notch signaling, L3MBTL3 interacts with RBPJ at Notch-responsive elements where it recruits KDM1A to repress Notch target genes.
C Loss of function of L3MBTL3 leads to de-repression of Notch target genes.
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active, yet-to-be inactivated, H3K4me2-rich RBPJ-bound sites. As
such, the L3MBTL3/KDM1A interaction may play a crucial role in
the early transition of RBPJ-bound sites from the active to the
repressed state.
Our results, together with previously reported observations,
support the hypothesis that our molecular model is conserved in
Drosophila. First, dL(3)mbt and Su(H) interact with each other and
co-localize at Notch target genes. Second, dL(3)mbt represses repor-
ters of Notch activity and Notch target genes [also observed in (Saj
et al, 2010)]. Third, both Notch and dL(3)mbt mediate critical devel-
opmental function in the same tissue, that is, neurogenesis in the
optic lobe (Wismar et al, 1995; Egger et al, 2010; Reddy et al, 2010;
Yasugi et al, 2010; Richter et al, 2011). Fourth, Notch and dL(3)mbt
interact genetically to control cell fate in the eye imaginal disk. Fifth,
dL(3)mbt overexpression causes a serrated wing (wing notching)
phenotype. Sixth, dL(3)mbt co-purifies with PF1, a PHD-finger
protein that was previously linked to Notch signaling (Moshkin
et al, 2009). It remains to be investigated whether PF1 regulates
Notch signaling as part of a dL(3)mbt-containing complex and/or as
part of a complex containing ASF1 and the H3K4me2/3 demethylase
LID (Goodfellow et al, 2007; Moshkin et al, 2009). Last but not
least, we note that Su(var)3-3, the fly homolog of KDM1A, geneti-
cally interacts with the Notch signaling pathway and also has a dual
role in modulating Notch signaling in Drosophila (Di Stefano et al,
2011). Moreover, the dL(3)mbt and Su(var)3-3 proteins co-purify in
LINT complexes isolated from third-instar larval brains (Meier et al,
2012). Altogether, these observations support a model in which dL
(3)mbt represses Notch signaling in Drosophila. It also suggests a
striking conservation of the Notch pathway/dL(3)mbt/Su(var)3-3
interaction from insects to mammals. Further studies are required
to characterize the molecular mechanisms in which Su(H),
dL(3)mbt, and Su(var)3-3 are involved on chromatin and to assess
whether Su(var)3-3’s ability to regulate Notch signaling depends on
dL(3)mbt.
To further explore the functional in vivo relevance of the RBPJ/
L3MBTL3 interaction in metazoans, we studied in C. elegans the
link between lag-1 and lin-61, the worm homologs of the RBPJ and
L3MBTL3 genes, respectively. Our results indicate that both genes
interact genetically during both embryonic and vulva development.
In C. elegans, spr-5 encodes an H3K4me2 demethylase homologous
to KDM1A. Remarkably, spr-5 was originally discovered in a genetic
screen as a suppressor of the egg-laying defective phenotype of sel-
12 (Jarriault & Greenwald, 2002); indeed, the product of sel-12 is a
key component of the c-secretase complex and the key role of this
complex for Notch signal activation was originally established in
C. elegans using a genetic approach (Levitan & Greenwald, 1995). In
one of their models, Jarriault and Greenwald speculate that SPR-5
contributes to the repression of Notch target genes by forming a
repressor complex with LAG-1 in the absence of Notch activation
(Jarriault & Greenwald, 2002), mirroring our RBPJ/L3MBTL3/
KDM1A model (Fig 7).
In conclusion, we identified a previously uncharacterized
RBPJ interactor, L3MBTL3, which contributes to the repression of
Notch target genes via KDM1A-dependent histone H3K4 demethy-
lation. Our in vivo data in Drosophila and C. elegans demon-
strate that the functional link between RBPJ and L3MBTL3 is
evolutionarily conserved, thus identifying L3MBTL3 as a univer-
sal modulator of Notch target genes in metazoans.
Materials and Methods
Appendix Supplementary Methods can be found in the Appendix file.
Yeast two-hybrid (Y2H)
Yeast two-hybrid (Y2H) screens were performed as previously
described (Dreze et al, 2010).
Affinity purification coupled to mass spectrometry analysis
U87-MG cells transfected with pcDNA3-HA-DEST encoding RBPJ,
L3MBTL3, or EGFP control were collected, washed with ice-cold
PBS, and lysed in ice-cold lysis buffer [50 mM Tris pH 7.8, 150 mM
NaCl, 0.5% NP-40, 10% glycerol, 2 mM NaF, 2 mM Na3VO4, and
Complete protease inhibitor (1× final, Roche, 05 056 489 001)].
HA-tagged proteins were affinity-purified with 50 ll of a-HA agarose
beads (Sigma, A2095) at 4°C for 2 h with rotation. Beads were
washed four times with lysis buffer, three times with washing buffer
(50 mM Tris pH 7.8, 100 mM NaCl, 0.1% NP-40), and three times
with 50 mM NH4HCO3. Proteins were eluted twice with 50 ll of 1%
ammonia (NH4OH; Sigma
, 338818), dried, and resuspended in
20 ll Laemmli sample buffer. Proteins were resolved via SDS–PAGE
and the whole gel lanes were cut into five pieces that were individu-
ally subjected to in-gel tryptic digestion, as previously described
(Shevchenko et al, 2006). Peptides were dried and analyzed via
LC-MS/MS system, as follows.
Peptides were resolved on a nano-capillary reverse phase column
(PicoFrit column, New Objective) using a 5–50% acetonitrile gradi-
ent at 300 nl/min and directly introduced into an ion-trap mass
spectrometer (LTQ XL, Thermo Fisher). Data-dependent MS/MS
spectra on the five most intense ions from each full MS scan were
collected (relative collision energy ~35%). Proteins were identified
by searching the data against Swiss-Prot human database (January
9th 2013) appended with decoy (reverse) sequences using the X!
Tandem/Trans-Proteomic Pipeline software suite (Pedrioli, 2010).
All peptides and proteins with a PeptideProphet (Keller et al, 2002)
and ProteinProphet (Nesvizhskii et al, 2003) probability score of
>0.8 (false discovery rate < 2% estimated using a target-decoy strat-
egy) were considered positive identifications. Proteins were consid-
ered potential RBPJ interactors if they were identified with two or
more mass spectra in both duplicate RBPJ AP-MS experiments but
not in the EGFP-negative AP-MS control experiments. Proteins iden-
tified in > 10% of the AP-MS experiments available in the CRAPome
database version 1.1, a contaminant repository for AP-MS data
(Mellacheruvu et al, 2013), were considered background contaminants
and removed from the analysis. The mass spectrometry proteomics
data have been deposited to the ProteomeXchange Consortium via
the PRIDE (Vizcaino et al, 2016) partner repository with the dataset
identifier PXD004196.
Isothermal titration calorimetry
Isothermal titration calorimetry experiments were carried out using a
MicroCal VP-ITC microcalorimeter. All experiments were performed
at 25°C in a buffer composed of 50 mM sodium phosphate pH 6.5
and 150 mM NaCl. Purified RBPJ core domain (53–474) and
L3MBTL3 (31–70) proteins were degassed and buffer-matched using
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size exclusion chromatography. Experiments were carried out with
10–20 lM RBPJ in the cell and 100–200 lM L3MBTL3 in the syringe.
Raw data were normalized to the corresponding L3MBTL3 heat of
dilution and fit to a one-site binding model using the ORIGIN soft-
ware. The following proteins were used: human L3MBTL3-(31-70)
(accession #KJ899798) and mouse RBPJ-(53-474) (accession
#P31266.1).
Chromatin immuno-precipitation (ChIP)
Cells were fixed for 15 min at room temperature with 1%
paraformaldehyde added directly to the medium, washed twice with
ice-cold PBS, and snap-frozen on dry ice. Cells were then lysed in
SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM TrisHCl pH 8.0),
sheared through a 27-gauge needle, and sonicated. Samples were
centrifuged for 20 min at 13,000 g, and the supernatant was diluted
at a 1:10 ratio with dilution buffer (0.01% SDS, 1% Triton X-100,
1.2 mM EDTA, 16.7 mM TrisHCl pH 7.5, 167 mM NaCl). Chro-
matin was incubated with 2.5 lg of the desired antibody overnight
at 4°C with rotation. Immuno-complexes were captured with 30 ll
of BSA-preblocked protein G Dynabeads (Invitrogen, 10009D) for
1 h at 4°C with rotation. Beads were washed once in low-salt
(150 mM NaCl, 2 mM EDTA, 0.1% SDS, 1% Triton X-100, 20 mM
Tris–HCl pH 7.5), once in high-salt (500 mM NaCl, 2 mM EDTA,
0.1% SDS, 1% Triton X-100, 20 mM Tris–HCl pH 7.5), once in
lithium chloride (25 mM LiCl, 1% NP40, 1% Deoxycholic Acid,
1 mM EDTA, 10 mM Tris–HCl pH 7.5), and twice with TE (10 mM
Tris–HCl pH 7.5, 1 mM EDTA) buffers for 5 min each. Chromatin
was eluted in 250 ll of elution buffer (1% SDS, 100 mM NaHCO3)
for 30 min at 42°C, and cross-linking was reversed by overnight
incubation at 65°C in presence of 50 mM (final concentration) NaCl.
Samples were incubated with RNase A (Qiagen, 19101), and DNA
was purified using the Qiagen PCR purification kit (Qiagen,
28106). Samples were analyzed via quantitative PCR (qPCR) using
the Power SYBR Green PCR master mix (Applied Biosystems,
4367662) and the CFX96 TouchTM Real-Time PCR Detection System
(Bio-Rad) according to manufacturer’s recommendations. Primers
used in ChIP experiments are listed in Table EV2 and their genome
location is shown in Appendix Fig S3A. A region of chromosome 8
(Chr8:127010162 + 127010260) was used as negative control
(NEG).
Gene expression analyses
Total RNA was extracted with TRIzol reagent (Ambion, 15596018)
according to manufacturer’s instructions and further purified with
the RNeasy Mini Kit (Qiagen, 74106). Five micrograms of RNA
was retro-transcribed in cDNA using oligo(dT)18-primed reverse
transcription and SuperScript III RT First-Strand kit (Invitrogen,
18080-051) as described by the manufacturer. The cDNA was
analyzed via qPCR analysis using the Power SYBR Green PCR
master mix (Applied Biosystems, 4367662) and the CFX96 TouchTM
Real-Time PCR Detection System (Bio-Rad) according to manufac-
turer’s recommendations. Data were normalized to the reference
gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). For
gene expression analyses in mature T cells, 1 lg of RNA was retro-
transcribed in cDNA using random hexamers and M-MuLV reverse
transcriptase (NEB). qPCRs were assembled with Absolute QPCR
ROX Mix (Thermo Scientific, AB-1139), gene-specific oligonu-
cleotides, and double-dye probes and analyzed using the StepOne-
Plus Real-Time PCR System (Applied Biosystem). Data were
normalized to the reference gene hypoxanthine-guanine phosphori-
bosyltransferase (HPRT). Primers used in RT-qPCR experiments are
listed in Table EV2.
Hidden Markov model profile alignment analyses
Hidden Markov model profile alignment analyses were performed
as previously described (Soding, 2005).
Drosophila melanogaster
All Drosophila stocks were maintained under standard conditions at
25°C unless otherwise stated. dL(3)mbtGM76, a temperature-sensitive
hypomorphic allele of dL(3)mbt, was generously provided by Dr. R.
Lehmann (Yohn et al, 2003). In Appendix Fig S8, the dL(3)mbtGM76
mutant is in heterozygosity with Df(3R)D605, a dL(3)mbt deficiency
line in which the whole dL(3)mbt locus is deleted. Df(3R)D605 was
obtained from Bloomington Drosophila Stock Center at Indiana
University, Bloomington, Indiana (Stock #823). The UAS-HA-dL(3)
mbt transgene was generated following a standard P-element-
mediated germline transformation. The E(spl)mc-GFP transgenic line
(Almeida & Bray, 2005) was kindly provided by Dr. S. Bray. The
UAS-dNICD line was previously described (Go et al, 1998). The
UAS-GFP and UAS-p35 lines were obtained from the Bloomington
Drosophila Stock Center at Indiana University, Bloomington, Indiana
(Stock #1521 and #5073, respectively). The expression of the UAS-
dependent transgenes was driven by E1-Gal4 (Pallavi et al, 2012),
vg-Gal4 (Bloomington Drosophila Stock Center #6819), or ptc-Gal4
(Bloomington Drosophila Stock Center #2017). For Fig EV4A–P, E1-
Gal4 and UAS-dNICD/CyO,tub-Gal80;E1-Gal4 virgin females were
crossed to UAS-HA-dL(3)mbt/CyO-Tb or w1118 males. For
Fig EV4Q–T, UAS-HA-dL(3)mbt/CyO-Tb virgin females were crossed
to UAS-dNICD/CyO,tub-Gal80;E1-Gal4 or UAS-GFP;E1-Gal4 males,
UAS-dNICD/CyO-Tb virgin females to UAS-GFP;E1-Gal4 males, and
UAS-GFP virgin females to UAS-GFP;E1-Gal4 males. To investigate
the combined loss of dL(3)mbt together with dNICD in the eye
imaginal disks, UAS-GFP/CyO,GFP;dL(3)mbtGM76/TM6B,Tb1, UAS-
dNICD/CyO,GFP;dL(3)mbtGM76/TM6B,Tb1, or UAS-dNICD males
were crossed with E1-Gal4 virgin females at non-permissive temper-
ature (31°C). For Fig 6D and E, vg-Gal4/CyO;UAS-GFP virgin females
were crossed to UAS-HA-dL(3)mbt/CyO-Tb or w1118 males. For
Appendix Fig S11, UAS-dNICD(X);vg-Gal4/CyO;UAS-GFP/TM6B,
Tb1,tub-Gal80 males were crossed to UAS-HA-dL(3)mbt/CyO-Tb or
UAS-GFP virgin females and only female progeny (containing UAS-
dNICD) were collected. Ptc-Gal4 experiments were performed by
crossing ptc-Gal4;tub-Gal80ts/CyO-TM6B,Tb1 virgin females to UAS-
HA-dL(3)mbt/CyO;UAS-GFP/TM6B,Tb1, UAS-dNICD, UAS-HA-dL(3)
mbt/CyO;UAS-dNICD, or w1118 males; crosses were maintained at
18°C (permissive temperature for Gal80ts) and transferred to 31°C
(restrictive temperature) for 26 h prior to harvesting.
Staining of eye disks was performed from third-instar larvae as
follows: eye disks were dissected in PBS, fixed in PLP buffer (2%
paraformaldehyde, 10 mM NaIO4, 75 mM lysine, 37 mM sodium
phosphate, pH 7.2) or 3.7% formaldehyde in 1× PBS, washed in
PBS-DT (0.3% sodium deoxycholate, 0.3% Triton X-100 in PBS) or
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1× PBS with 0.1% Triton X-100, and incubated with the desired
primary antibody. After several washes, disks were incubated with
the desired secondary antibody (Alexa 350-, 488-, 594-, or 647-conju-
gated, Molecular Probes, 1:100–1:1,000) and washed in PBS-T
(0.1% Triton X-100 in PBS). The samples were mounted in Fluoro-
Guard Antifade Reagent (Bio-Rad) or Vectashield (Vector Laborato-
ries, H-1000). EdU (5-ethynyl-20-deoxyuridine) assays were
performed as previously described (Pallavi et al, 2012).
Caenorhabditis elegans
Caenorhabditis elegans worms were maintained under standard
conditions (Stiernagle, 2006). To score embryonic lethality, mixed
populations of N2 (N2 refers to the WT strain) and lag-1(om13)
animals were synchronized at L1 larval stage (Porta-de-la-Riva et al,
2012). L1 animals were seeded on RNAi plates, that is, empty vector
control or lin-61(RNAi) plates and let grown for 3 days at 25°C.
Subsequently, for each study group, eight L4 animals (P0) were
singled out, transferred onto new plates, and assessed for embryonic
lethality, that is, 1 day after removing the P0 mothers from the
plates, the proportion of embryos that had failed to hatch were
determined for each group. Scoring of the protruding vulva (Pvl)
phenotype was performed by culturing the animals for two genera-
tions. P0 animals were grown for 36 h at 25°C. Subsequently, for
each study group, eight L4 animals (P0) were singled out and trans-
ferred onto new Nematode Growth Medium (NGM) worm culturing
media plates where the proportion of animals in the progeny (F1)
was assessed for the presence of protruding vulvas.
Data availability
The mass spectrometry proteomics data from this publication have
been deposited to the ProteomeXchange Consortium via the PRIDE
(Vizcaino et al, 2016) partner repository with the dataset identifier
PXD004196. The ChIP-Seq data from this publication have been
deposited in NCBI’s Gene Expression Omnibus (Edgar et al, 2002)
and are accessible through GEO Series accession number
GSE100375: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE100375.
Expanded View for this article is available online.
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